{
  "abstract": "Patients with lung cancer treatment might not avoid cardiovascular events",
  "authors": [
    {
      "affiliations": [
        "Victorian Cancer Registry, Cancer Council Victoria, Melbourne, Australia"
      ],
      "name": "Jianrong Zhang"
    },
    {
      "affiliations": [
        "Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"
      ],
      "name": "Xiaoyan Liu"
    },
    {
      "affiliations": [
        "Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"
      ],
      "name": "Yan Xu"
    }
  ],
  "title": "Cardiovascular toxicity risks in treating EGFR-mutated lung cancer",
  "uid": "c11c713d-9f42-5f3a-97b4-148ec5bb5028"
}